Welcome to the R2platform DataScience Annals in 2023

Welcome to the R2platform DataScience Annals. This blog will serve as a low-level entry point to provide some insights into datascience that may also be applicable for users of the http://r2platform.com .

Comments

Post a Comment

Popular posts from this blog

Plotting updates for the open online R2platform. The data science platform for biomedical researchers

Image
  Ploting updates for the R2platform We have been working hard to bring you the latest update in the R2 genomics analysis and visualization platform ( https://r2.amc.nl ); the goto web-tool for biomedical researchers to test their hypotheses on public omics data, without the need for bioinformatics or coding expertise. In the latest update, we have made substantial changes to many of the plots that can be produced within R2. Many of the adaptable parameters have now become interactive and are placed under the 'gears' icon. The 'gears' icon Let's have a look at a gene within one of the many resources that are publicly available in R2. We will look at the GATA3 gene in an integrated resouce where samples from both GTEx as well as the TCGA have been integrated and 'batch corrected' to get an immersive view of expression in normal as well as cancer samples. We first select our resource of interest by clicking on 'select a data set'. and then find the ...
Read more

R2: An Interactive Online Portal for Tumor Subgroup Gene Expression and Survival Analyses, Intended for Biomedical Researchers

Image
  R2: An Interactive Online Portal for Tumor Subgroup Gene Expression and Survival Analyses, Intended for Biomedical Researchers Genomic data from The Cancer Genome Atlas (TCGA) project has enabled comprehensive molecular profiling of diverse cancer types. The extensive sample size within TCGA provides an invaluable resource for investigating tumor heterogeneity. Effective exploration of this dataset by researchers and clinicians is essential for discovering novel therapeutic and diagnostic biomarkers. While numerous computational tools have been developed to analyze specific aspects of TCGA data, there remains a need for platforms that facilitate the study of gene expression variability and its association with clinical outcomes across tumors. Here, we introduce the  R2 Platform , an intuitive and interactive web portal designed for in-depth analysis of TCGA gene expression data. The portal leverages TCGA Level 3 RNA-seq and clinical data from 31 cancer types. With its user-f...
Read more

Explore by yourself, the pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets, in the R2 Genomics Analysis & Visualization platform

Image
New datascope available in R2: open online Genomics Analysis and Visualization Platform ( https://r2.amc.nl ). "The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets" by Jaco Knol et. al under the guidance of Connie Jimenez published in Cancer Cell. "Most cancer proteomics studies to date have focused on a single cancer type. We report The Pan-Cancer Proteome Atlas (TPCPA) based on data-independent acquisition mass spectrometry, to better understand cancer biology and identify therapeutic targets and biomarkers. TPCPA includes 9,670 proteins derived from 999 primary tumors representing 22 cancer types. All TPCPA data can be queried in a dedicated web resource." The datascope can be acccessed here http://r2platform.com/TPCPA dataviz, proteomics, datascience, cancer
Read more